Exabis Library
Welcome to the e-CCO Library!
P617: Switching from an intensified regimen of infliximab to a subcutaneous standard dose in adults with Inflammatory Bowel Disease: our experience in a tertiary hospital.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P617: Trends in Pediatric Inflammatory Bowel Disease-attributable direct costs: A Canadian population-based analysis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P618 Post-operative Crohn’s disease patients undergoing colonoscopy require significantly more analgesia and sedation compared with a non-IBD population
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P618: Long-term real-world data of Ustekinumab in Ulcerative Colitis – the Stockholm Ustekinumab study – STOCUSTE
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P618: Post-operative pain following laparoscopic right hemicolectomy for Crohn’s disease a comparative study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P618: Pre-operative oral enteral nutritional optimisation for Crohn’s disease: A retrospective UK tertiary IBD centre cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P618: Rapidity of onset of response to adalimumab in luminal Crohn's disease. Data from RAPIDA trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P618: Treatment outcomes of patients with Crohn’s disease and complex perianal fistula in five European countries: the PREFACE retrospective study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P618: Vedolizumab acute infusion reactions in inflammatory bowel disease patients: results of a multi-centre retrospective observational cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P619 Efficacy of zinc acetate hydrate administration for zinc deficiency in patients with inflammatory bowel disease: a multi-centre retrospective study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P619: Incidence of collagenous colitis in NHS Lothian: a population-based study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P619: Inflammatory bowel disease meets fertility: a physicians and patients survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P619: Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P619: Patterns of Anti-TNF Prescribing & Therapy Outcome in a Large Multicentre Cohort of Inflammatory Bowel Disease Patients
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P619: Systematic review: Psychosocial factors associated with pain in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P619: Tofacitinib for the treatment of resistant ulcerative colitis: the University of Chicago experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P620 Maintenance of clinical remission with SB5 biosimilar after switch from adalimumab originator: Real-life experience of a tertiary referral centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P620: Can ustekinumab trough and antidrug antibody levels post induction predict treatment failure?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P620: Differences in illness perceptions of Inflammatory Bowel Disease (IBD) between Healthcare Practitioners (HCPs) and patients in a UK tertiary IBD centre.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P620: Golimumab in ulcerative colitis: A multi-centre real-world experience
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM